Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritis
Abstract Background Alongside its clinical success, checkpoint blockade has also given rise to a set of immune-related adverse events (irAEs). In addition to causing considerable morbidity and even mortality, irAEs may limit the success and scope of immunotherapy. Most irAEs arise at mucosal barrier...
Main Authors: | Elisa Bello, Justine V. Cohen, Mari Mino-Kenudson, Michael Dougan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-02-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0524-1 |
Similar Items
-
Ipilimumab cystic hypophysitis mimicking metastatic melanoma
by: John Wallace, BS, et al.
Published: (2018-06-01) -
Severe Gastritis after Administration of Nivolumab and Ipilimumab
by: Yoshito Nishimura, et al.
Published: (2018-08-01) -
Campylobacter pylori Detection in Gastric Mucosa: Association with Gastritis
by: Alain Paradis, et al.
Published: (1988-01-01) -
Ipilimumab: Melanoma and beyond
by: Vishal Patel, et al.
Published: (2011-01-01) -
Gastritis, Duodenitis and Peptic Activity of the Human Gastric and Duodenal Mucosa
by: Roca, M.
Published: (1975)